ADIPOQ and metabolic syndrome: Additionally, future studies that include outcome measures such as insulin resistance, diabetes, and metabolic syndrome as well as heart disease and rheumatological conditions are needed to further elucidate whether adiponectin is a key link to explain the ethnic differences in disease risk in Asians and Caucasians.